Vytrus Biotech S.A. (VYT) — Cash Flow Reinvestment Rate

Latest as of December 2022: 2.19x

Vytrus Biotech S.A. (VYT) has a Cash Flow Reinvestment Rate of 2.19x as of December 2022, reinvesting €494.16K (capex €494.16K ) from operating cash flow of €225.55K. Explore Vytrus Biotech S.A. (VYT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.19x
(Capex + Investments) / Operating CF

Total Reinvested

€494.16K
Capex + Investments

Operating Cash Flow

€225.55K
EUR

Capital Expenditures

€494.16K
EUR

Vytrus Biotech S.A. Cash Flow Reinvestment Rate (2021–2025)

Historical reinvestment intensity for Vytrus Biotech S.A. across 5 annual periods. Also explore Vytrus Biotech S.A. total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Vytrus Biotech S.A. (2021–2025)

Year-by-year capital reinvestment analysis for Vytrus Biotech S.A.. For live market cap and broader valuation context, see how much is Vytrus Biotech S.A. worth.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.71x €2.76 Million €3.90 Million €2.68 Million ▲ +8.1%
2024 0.65x €1.21 Million €1.84 Million €1.20 Million ▼ -49.9%
2023 1.31x €1.18 Million €904.39K €1.17 Million ▼ -44.0%
2022 2.33x €526.44K €225.55K €494.16K ▲ +245.3%
2021 0.68x €302.78K €447.92K €271.82K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow